ASC - Autism Study

Clinical trial NCT05602116 · COMPLETED

Trial details

NCT number: NCT05602116
Sponsor: Cell to Cure ApS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autism Spectrum Disorder Gastrointestinal Dysfunction Leaky Gut Syndrome Mesenchymal Stromal Cells Inflammatory Bowel Diseases

Start date: 2023-06-09
Primary completion: 2024-06-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.